{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:02:24Z","timestamp":1778155344989,"version":"3.51.4"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221567","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T17:31:45Z","timestamp":1569346305000},"page":"e0221567","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness, safety\/tolerability of OBV\/PTV\/r \u00b1 DSV in patients with HCV genotype 1 or 4 with\/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice \u2013 Vie-KinD study"],"prefix":"10.1371","volume":"14","author":[{"given":"Mar\u00eda-Carlota","family":"Londo\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Riveiro-Barciela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Ahumada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Mu\u00f1oz-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-0779","authenticated-orcid":true,"given":"Merc\u00e9","family":"Roget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Devesa-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen A.","family":"Navascu\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Baliellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Aldamiz-Echevarr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda L.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjam\u00edn","family":"Polo-Lorduy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Benlloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Bonet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Garc\u00eda-Samaniego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Jim\u00e9nez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senador","family":"Mor\u00e1n-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngeles","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Gea-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Mart\u00edn-Granizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0560-3260","authenticated-orcid":true,"given":"Lu\u00eds","family":"Morano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel A.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"de los Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Laguno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0750-0185","authenticated-orcid":true,"given":"Juan Emilio","family":"Losa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Montero-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"de \u00c1lvaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Manzanares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Mallolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermina","family":"Barril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Gonz\u00e1lez-Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Garc\u00eda-Buey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"pone.0221567.ref001","unstructured":"Hepatitis C. World Health Organization. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/"},{"key":"pone.0221567.ref002","first-page":"13","article-title":"Estudio de prevalencia de infecci\u00f3n por los virus de la hepatitis b y c en Catalu\u00f1a","volume":"40","author":"S Rodr\u00edguez-Tajes","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"pone.0221567.ref003","first-page":"95","article-title":"Estudio de prevalencia de serolog\u00eda de hepatitis c en un \u00e1rea de salud con poblaci\u00f3n Rural","volume":"40","author":"M Fern\u00e1ndez Bermejo","year":"2017","journal-title":"Gastroenterol Hepatol"},{"issue":"7","key":"pone.0221567.ref004","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.","volume":"150","author":"Z Younossi","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0221567.ref005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1665-2681(19)31002-6","article-title":"pact of sustained virologic response on quality of life in chronic HVC carriers","volume":"12","author":"R Daltro-Oliveira","year":"2013","journal-title":"Ann Hepatol."},{"issue":"3","key":"pone.0221567.ref006","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jhep.2005.11.046","article-title":"Depression, anemia and health-related quality of life in chronic hepatitis C","volume":"44","author":"AA Dan","year":"2006","journal-title":"J Hepatol"},{"issue":"3","key":"pone.0221567.ref007","first-page":"273","article-title":"Documento de consenso SEN-semFYC sobre la enfermedad renal cr\u00f3nica.","volume":"28","author":"R Alc\u00e1zar","year":"2008","journal-title":"Nefrolog\u00eda"},{"issue":"11","key":"pone.0221567.ref008","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jvh.12413","article-title":"A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection","volume":"22","author":"H Park","year":"2015","journal-title":"J Viral Hepat"},{"issue":"3","key":"pone.0221567.ref009","first-page":"33","article-title":"Estudio y seguimiento de la hepatitis C cr\u00f3nica en hemodi\u00e1lisis: conclusiones del estudio SHECTS","volume":"4","author":"R Garc\u00eda-Agudo","year":"2013","journal-title":"Nefrologia Sup Ext"},{"issue":"9","key":"pone.0221567.ref010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2893.2012.01633.x","article-title":"Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?","volume":"19","author":"F Fabrizi","year":"2012","journal-title":"J Viral Hepat"},{"issue":"2","key":"pone.0221567.ref011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4254\/wjh.v7.i2.213","article-title":"Management of patients with hepatitis C infection and renal disease","volume":"7","author":"C Bunchorntavakul","year":"2015","journal-title":"World J Hepatol"},{"issue":"12","key":"pone.0221567.ref012","first-page":"e83","article-title":"Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users","volume":"2","author":"PH Lin","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"34","key":"pone.0221567.ref013","doi-asserted-by":"crossref","first-page":"12132","DOI":"10.3748\/wjg.v20.i34.12132","article-title":"Hepatitis C virus infection in the human immunodeficiency virus infected patient","volume":"20","author":"LN Clausen","year":"2014","journal-title":"World J Gastroenterol"},{"key":"pone.0221567.ref014","first-page":"135","article-title":"Chapter 4.3 \u2013Hepatitis C and HIV Coinfection in Developing Countries. In: Hepatitis C in Developing Countries.","author":"O Tastan Bishop","year":"2018","journal-title":"Current and Future Challenges"},{"issue":"15","key":"pone.0221567.ref015","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.4254\/wjh.v7.i15.1936","article-title":"Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a \u201cspecial population\u201d?","volume":"7","author":"DE Karageorgopoulos","year":"2015","journal-title":"World J Hepatol"},{"issue":"4","key":"pone.0221567.ref016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-0031-1297928","article-title":"The era of direct-acting antivirals has begun: the beginning of the end for HCV?","volume":"31","author":"ML Vachon","year":"2011","journal-title":"Semin Liver Dis"},{"issue":"9","key":"pone.0221567.ref017","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.dld.2015.04.003","article-title":"Interferon-free therapy for hepatitis C: The hurdles amid a golden era.","volume":"47","author":"M Colombo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"pone.0221567.ref018","unstructured":"EASL Recommendations on Treatment of Hepatitis C 2018. Available from: https:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(18)31968-8\/fulltext"},{"key":"pone.0221567.ref019","unstructured":"HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Patients with renal impairment. Available from: https:\/\/www.hcvguidelines.org\/unique-populations\/renal-impairment"},{"issue":"suppl. 1","key":"pone.0221567.ref020","first-page":"744A","article-title":"Effect of chronic kidney disease on the pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir in subjects with HCV genotype 1 infection","volume":"62","author":"DL Shuster","year":"2015","journal-title":"Hepatology"},{"issue":"suppl. 1","key":"pone.0221567.ref021","first-page":"733A","article-title":"Effect of renal function on the pharmacokinetics of Ombitasvir\/Paritaprevir\/Ritonavir Dasabuvir and ribavirin in over 2000 subjects with HCV GT1 infection","volume":"62","author":"AR Polepally","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"pone.0221567.ref022","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1053\/j.gastro.2016.02.078","article-title":"Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease","volume":"150","author":"PJ Pockros","year":"2016","journal-title":"Gastroenterology"},{"issue":"suppl. 1","key":"pone.0221567.ref023","first-page":"441A","article-title":"RUBY-I: safety and efficacy of ombitasvir\/paritaprevir\/ritonavir and dasabuvir with or without ribavirin in adults with genotype 1 chronic hepatitis c virus (HCV) infection with severe renal impairment or end-stage renal disease.","volume":"64","author":"JM Vierling","year":"2016","journal-title":"Hepatology"},{"issue":"suppl. 1","key":"pone.0221567.ref024","first-page":"470A","article-title":"RUBY-II: Efficacy and Safety of a Ribavirin-Free Ombitasvir\/Paritaprevir\/Ritonavir \u00b1 Dasabuvir Regimen in Patients with Severe Renal Impairment or End-Stage Renal Disease and HCV Genotype 1a or 4 Infection.","volume":"64","author":"EJ Gane","year":"2016","journal-title":"Hepatology"},{"key":"pone.0221567.ref025","unstructured":"https:\/\/www.niddk.nih.gov\/health-information\/health-communication-programs\/nkdep\/lab-evaluation\/gfr\/estimating\/Pages\/estimating.aspx)"},{"key":"pone.0221567.ref026","unstructured":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD). Available from: https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/2017-KDIGO-CKD-MBD-GL-Update.pdf"},{"issue":"6","key":"pone.0221567.ref027","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jvh.12664","article-title":"Therapy with ombitasvir\/paritaprevir\/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience","volume":"24","author":"R Mu\u00f1oz-G\u00f3mez","year":"2017","journal-title":"J Viral Hepat"},{"issue":"1","key":"pone.0221567.ref028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/14656566.2017.1419185","article-title":"Advances in the treatment of HIV\/HCV coinfection in adults","volume":"19","author":"S Schlabe","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"pone.0221567.ref029","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12879-016-1681-1","article-title":"Hepatitis C treatment initiation in HIV-HCV coinfected patients","volume":"16","author":"L Cotte","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pone.0221567.ref030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/hiv.12579","article-title":"Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?","volume":"19","author":"J Bischoff","year":"2018","journal-title":"HIV Med"},{"issue":"8","key":"pone.0221567.ref031","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/S2352-3018(15)00114-9","article-title":"Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial","volume":"2","author":"JK Rockstroh","year":"2015","journal-title":"Lancet HIV"},{"key":"pone.0221567.ref032","unstructured":"HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Patients with HIV\/HCV coinfection. Available from: https:\/\/www.hcvguidelines.org\/unique-populations\/hiv-hcv"},{"issue":"10","key":"pone.0221567.ref033","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/jvh.12708","article-title":"Real-world experience with the all-oral, interferon-free regimen of ombitasvir\/paritaprevir\/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry","volume":"24","author":"TM Welzel","year":"2017","journal-title":"J Viral Hepat"},{"issue":"6","key":"pone.0221567.ref034","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jhep.2017.01.028","article-title":"Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort","volume":"66","author":"JL Calleja","year":"2017","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"pone.0221567.ref035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/liv.13293","article-title":"Hepatitis C: efficacy and safety in real life","volume":"37","author":"R Flisiak","year":"2017","journal-title":"Liver Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:21:05Z","timestamp":1589016065000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221567"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221567","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]}}}